Introduction
In the last decades, monoclonal antibodies (mAbs) have become increasingly important in terms of medical research, diagnosis, and therapy. They constitute more than 30% of total biopharmaceutical production 1, 2 and are the largest class of proteins currently under clinical trials. 3 Several mAbs have been approved for use in therapeutic applications, as summarized in Table 1 (for a more extensive and detailed list that includes mAbs approved for diagnostic purposes as well as mAbs under development, consult the Immunogenetics (IMGT) webpage http://imgt.cines.fr/textes/IMGTrepertoire/ GenesClinical/monoclonalantibodies/#Approval_antibodies).
The major percentage of the mAbs approved and under trials is produced by mammalian cells 4 because of their ability to perform human-like post-translational modifications that result in full-active product. 5 Generally, therapies with mAbs require the use of high doses over prolonged periods of time. 6 Therefore, the production of these products needs to be done at large scale to meet the market demands. 6 Moreover, it is desirable to have economic, highly productive, and consistent manufacturing processes, able to deliver health benefits to patients in a quick way. 6 The achievement of an economic highly productive process currently constitutes a major biotechnological challenge. 7 With this aim, several production systems have been developed, with frequent updates and improvements, resulting in a wide range of available technologies for largescale mAb production. In this article, it is intended to give a critical review of these systems, pointing their strengths, recent advances, as well as major limitations that still need to be surpassed.
Production Systems
In the laboratory, conventional low-density cell culture methods are used for production of mAbs at low concentrations (1-100 lg/mL). 3 This small-scale cell culture provides sufficient amounts for research and diagnostic purposes. However, the market needs for therapeutic products require large-scale manufacturing capacity, 3 with demands on mAbs of 100-1,000 kg/year, which can only be achieved in large bioreactors and by efficient processes that produce several kg/day. 8, 9 Systems for small-scale production Small-scale culture systems usually have a simple design and a low level of instrumentation and control. 10 In these systems, cells are usually grown adherently, because this is the normal/physiological mode of growth of mammalian cells, and the process of adaptation to suspension can be time-consuming. Nevertheless, because adherent culture has the major drawback of limited surface area for growth, 11 some small-scale systems for suspension culture have also been developed.
Correspondence concerning this article should be addressed to M. Henriques at mcrh@deb.umiho.pt. Adherent Culture. For adherent culture, the typical systems used in laboratory scale are T-flasks, petri dishes, and multiwell plates. These systems are maintained in a humidified carbon dioxide (CO 2 ) incubator to provide a controlled environment for cell growth.
In anchorage-dependent cultures, the cell concentration possible to achieve is directly proportional to the surface area available for growth. 10 Therefore, the scale increase for these cultures involves the amplification of the growth surface. One way to provide larger surface areas is to use multilayered stacked plate systems, such as Cell Factory (NalgeNunc) and CellCube (Costar) (Figures 1a,b) . [12] [13] [14] In these systems, because of the increased surface-to-volume ratio, high cell concentrations can be achieved, which in the case of CellCube is added by the continuous medium circulation that supplies oxygen and nutrients to the cells. 14 However, heterogeneity of fluid flow has been observed in this system, resulting in nonuniform cell growth patterns and shear stress.
14 Furthermore, both Cell Factory and CellCube operation are usually tedious, time-consuming, and with inefficient utilization of space. 13 Another system commonly used to increase surface area, and therefore obtain higher cell and product concentrations, is roller bottles (Figure 1c) . 15, 16 In this technology, cells are seeded into the roller bottles that are filled to 10-30% of their capacity with medium and slowly rotated, allowing cells to adhere and assuring their regular wetting. 4 Apart from the increased surface area for growth and low shear rates, 17, 18 roller bottles have other advantages, such as very high oxygen transfer rates (supplied by the ample bottle ''headspace'' 4 ) and the ease of scale-up that is simply done by increasing the number of units handled in parallel. 4, 19 However, the handling of a large number of roller bottles simultaneously can be tedious, 13 labor-intensive, 20 prone to contamination, and difficult to control product quality. 20 This has led to the development of automated systems to handle roller bottle cultures (e.g., the RollerCell system marketed by Cellon, SA 21 ). 22 Furthermore, roller bottles only operate as batch or fedbatch systems, which prevents them from achieving cell densities and antibody secretion rates as high as the ones attained in continuous perfusion systems. 4, 19, 23 A possible way to overcome this limitation is to use roller bottles operating on apparatuses that provide a continuous supply of nutrients and oxygen to the cells. 19, 23 This can be done by using a pump that delivers the culture medium from a fresh medium reservoir into the growth chamber of the bottle (spiroll bottle 19 ) or by using a medium recirculation loop (CPRB-continuous perfusion roller bottle 23 ) (Figures 1d,e ). Higher cell densities can then be achieved in these models, as well as maintenance of cultures over longer periods of time, resulting in increased volumetric productivities.
All the systems mentioned, although achieving higher cell concentrations and productivities than the traditional laboratory methods of culture (T-flask, petri dishes, and multiwell plates), are not commonly used for large-scale industrial production. This is due to their limitations in terms of high costs (labor, equipment, and consumables), considerable risk of contamination, and poor control of culture parameters. 10 Suspension Culture. When compared with adherent culture, in suspension systems cell concentration is independent of the surface area available, which allows increased cell densities and consequently higher product concentrations. The systems used for adherent culture (i.e., T-flasks, petri dishes, and microtiter plates) can also be used for suspension cell propagation. 10 Particularly, shaken microtiter plates are highly used for purposes of screening and optimization in cell culture, 24 although the problem of evaporation limits its use for extended cultures. 4 For the same purpose of screening, in media development trials, centrifuge tubes with ventilated caps can also be used for culturing cells in suspension. 10, 25 However, despite the fact that adherent systems can be used for suspended cultures, more adequate methods are available ( Figure 2 ). These include shake flasks, 26, 27 roller bottles, 19 and spinner flasks, 10 that have been used for cultivation of many different suspension cell lines for a variety of applications within preclinical research, process development, and for expansion of inoculum in production. 4, 10 The advantages of these suspension-specific systems comparing to the stationary methods include the non-cell-adherent materials used in their construction, as well as a proper design that are ideal for maintaining a suspension culture without problems of cell deposition or adherence. Although oxygen transfer is improved because of the larger gas/liquid surface and agitation, oxygen limitations are still a major drawback that does not allow high cell densities to be achieved. 4, 10, 28 Attempts to minimize this problem include sparging with Oxygen (O 2 )/air, the superspinner 29 ( Figure  2c ) that uses microporous membranes through which an air/ CO 2 mixture is pumped, and the CELLine 1000 device, 30 ( Figure 2d ) which has separate growth and medium chambers that allow more frequent and easier medium changes, with direct oxygenation and easy product isolation.
This system improves oxygen transfer rates, supporting high cell density (10 7 -10 8 cells/mL) and generating a high mAb concentration (0.7-2.5 mg/mL) within a period of 2 months, but is still limited to a 1-2 L volume of culture per batch. 30 The limitations of oxygen transfer and poor control of the culture parameters inherent to the aforementioned devices only allow for small-or medium-scale production. To achieve large-scale production, other systems had to be developed. 
Systems for large-scale production
The high demands for mAbs gave rise to the development of different bioreactors and culture systems for large-scale production in mammalian cell culture. These systems are constantly evolving to overcome some key barriers of largescale processing, such as oxygen supply limitations, waste product accumulation, the need for more sophisticated process control, shear sensitivity of animal cells, and the challenges of growing adherent cell lines at large scale. 31 Although some of these limitations have been surpassed, new ones have arisen. These include the maximization of the productivity while maintaining product quality, removal of all animal-derived components from cell culture medium, minimization of contamination during large-scale production, and control of CO 2 removal. 9 For large-scale production, suspension cell-culture processes are usually the system of choice. Nevertheless, adherent culture systems are also being developed, because they can be indispensable to certain applications.
Suspension Culture. Suspension cell systems are the usual choice for large-scale production because of the wellunderstood principles of scale-up, the ease of process control, 9 and the higher surface-to-volume ratio when compared with the adherent cell systems, 10 which result in more efficient processes.
For culturing cells in suspension, agitation and aeration are critical and can cause shear damage to the cells. These negative effects can be minimized by using shear-protecting agents, such as Pluronic F68 (proposed mechanism of action reviewed by Gigout et al. 32 ) or by appropriate reactor design and control. 9 It should be taken into account that although many cell types can be adapted to suspension, this is still limiting the choice of cell line and is time-consuming, increasing the timeline for process development.
The most commonly used suspension culture systems for production of mAb are the stainless steel stirred tank, 33 the airlift, 34 and disposable 28 bioreactors. Some specific advantages and limitations of these reactors, as well as recent developments, will be addressed later.
Stainless steel stirred tank bioreactor. The traditional and most widely used bioreactor type for mAb production is the stainless steel stirred tank bioreactor (STR) ( Figure  3) . 9, 10, 35 This is mainly due to the broad knowledge and experience acquired from microbial fermentation. 10 This results in better characterized and familiar scale-up principles and mechanical designs for sterilization and cleaning, when compared with other bioreactor types. 10 This knowhow also facilitates the regulation/approval of the process of production, because the regulatory agencies are experienced with products obtained from STR in different modes of operation. 10 Other advantages of STR include the high mass/gas-transfer coefficient values, 35 the high flexibility 35 in terms of applicable working volumes (up to 15,000 L 37 ), and the suitability for different cell types, operation modes, and products, which results in reduction of costs. 10 Furthermore, good culture conditions such as temperature control, culture pH, dissolved oxygen (DO) level, low agitation rate, and aeration with mixed gas and well-controlled conditions are supported and fulfilled by this bioreactor. 35 This accurate control of culture conditions allows robust mAb production in STR with most commercially available cell lines. However, the productivities obtained could be further improved if the factors causing stress to the cells could be suppressed, such as shear and bubble damage caused by mechanical agitation and gas sparging. 38 Consequently, it is one of the main aims in reactor design, with advances being made on the impeller design, to minimize shear damage to cells and consequently improve cell density and mAb production. 39 Air-lift reactors. In addition to STRs, airlift reactors ( Figure 4 ) are also widely used for suspension animal cell culture. 41, 42 They can be considered as a type of bubble column, due to mixing being provided by the introduction of gas bubbles at the base of a tall column. 43 This results in gentler mixing action and suitability for shear-sensitive cells than STR. 43 Nevertheless, gas sparging is still a concern in terms of cell damage and death, and therefore it is an important factor to regard in reactor design and scale-up. 38 Other advantages of air-lift bioreactors over STR are the easiest scale-up and the more reliable sterile operation (consequence of the absence of moving parts and mechanical seals). 38, 44 Nevertheless, the air-lift reactor is not as widely used as STR because of less know-how, but also to the limited flexibility in terms of working volume (only up to 2,000 L 44, 45 ) and limited suitability for microcarrier culture, 10 which has been considered impractical. 46, 47 Disposable bioreactors. Although stainless steel bioreactors are still the major choice for large-scale production, 6 in recent years advances have been observed in disposable systems for cell cultivation that have risen the interest in their use at production scale. 48 Disposable bioreactors can be very advantageous for the manufacturing process in the areas of cleaning, sterilization, set-up, and turn-around time between runs. 6, 48, 49 Furthermore, they eliminate the chance of cross-contamination between process runs, 49 reduce the expensive capital investment associated with stainless steel bioreactors, 6 and result in substantial cost savings in initial investment, labor, equipment, facility design, and validation. 49 Indeed, validation is less complex because of the elimination of the sterilization and cleaning procedures, as well as the use of fewer reusable components that result in fewer items to be tracked. 49 However, these bioreactors are still limited by their culture volume and, therefore, are mostly used for smaller scale cultivations, for seed culture expansion and for inoculation of the large conventional bioreactors. 49, 50 Nevertheless, bioreactors up to 2,000 L are currently available, such as the HyClone V R , Millipore Among the disposable reactors available, the wave bioreactor ( Figure 5 ) is particularly relevant, 28, 51 with strong demand for applications of plant, 52 insect, 28, 53 and different mammalian cells. 28, [54] [55] [56] This bioreactor system, first described by Singh, 28 consists of a disposable, flexible, sterile plastic bag (CellBag TM ) that sits on a rocking thermoplatform. 28, 53, 57 The cellbags are filled with cell suspension up to half their capacity (from 2 L, for small-scale culture, up to 1,000 L, for large-scale culture) and inflated with air. 28, 53, 57 The rocking motion of the cellbag induces undulation to ensure good nutrient distribution, off-bottom suspension, and a greater and constantly renewed surface that increases oxygen transfer without shear damage. 28, 53, 57 Oxygen supply is given by headspace aeration, 48, 53 and the headspace can be filled or continuously gassed with the desired gas mixture. 28 The system can operate in CO 2 incubators or stand-alone in combination with a heater and a CO 2 control unit. 10, 28 The wave bioreactor can be valuable for cell/gene therapy applications (primary cell cultivation, rapid expression/ screening of hundreds of genes), 28 rapid material supply during early stage clinical studies, 49 process development and clinical manufacturing. 57 It operates in different culture modes, including perfusion, which can be performed using different cell-retention mechanisms for the high-efficient production of mAbs. 58 The combined advantages of a fully closed, disposable system with process monitoring capabilities (pH and DO) make the wave bioreactor highly attractive over traditional systems for animal cell culture, such as shake flasks and STR, 57 although with limitations in culture volume.
Adherent Culture. Although large-scale production of mAbs by mammalian cells is usually done in suspension culture, continuous efforts are being made to develop high-density adherent cell culture systems. This is a consequence of the adherent growth being the natural state for mammalian cells, 4 with problems related to suspension culture, such as sensitivity to hydrodynamic shear forces 59, 60 and time-consuming processes of adaptation, 61, 62 not being an issue in the adherent cultures.
However, attachment-dependent cell culture has, as mentioned earlier, the major limitation of low surface-to-volume ratio that results in low cell densities. Therefore, to scale-up these cultures with higher cell densities, it is important to maximize the surface-to-volume ratio. 9, 11 On account of that, many immobilization systems/bioreactors have been developed, where cells are usually immobilized on/inside particles that are suspended in culture medium. 63 The most wellknown system for culture of adherent cells is microcarrier culture, 64, 65 which can be performed in different bioreactors, with STR being the most common. 66 Other immobilization systems include small beads of different materials 67 (agarose, 68 gelatin and alginate 67, 69 ), gel particles (collagen 70 ), membranes, [71] [72] [73] and fibers. [74] [75] [76] [77] All these systems are ideal for perfusion culture, 11 which increases cell concentration in the reactor (10 7 -10 8 cells/mL) and extends the productive lifetime of cells, 60, 74 resulting in increased levels of mAb productivity when compared with suspension culture. 60, 74 Furthermore, immobilized cell reactors have other advantages such as simplifying downstream processing because of cell retention, 78 which provides cell-free products, 60, 74 creating a favorable microenvironment for cell growth and mAb production. 60, 78 However, these bioreactors still have limitations that result in a problematic long-term use and scale-up. For example, in bioreactors that use beads, destruction of the beads can occur with cell leaking and washout, resulting in declined mAb production over time. 77 In membrane and fiber bioreactors, cell degeneration and accumulation of nonviable cells over longterm operation occurs, with biomass build-up, resulting in poor mass transfer. 79 The particular advantages and limitations of each of the main immobilization systems used are reviewed next.
Microcarrier systems. The development of microcarrier cultures was a major breakthrough for anchorage-dependent cells. 80 Microcarriers are microscopic particles that are easily maintained in suspension in liquid medium, providing a pseudo-suspension culture for anchorage-dependent cells. 4, 81 They increase the surface area available for cell adhesion and growth, allowing high cell density and productivity. 82, 83 Microcarrier characteristics, such as size, density, and surface charge, are important for their applicability in industrial technologies. 10, 11 They should be small to maximize growth surface area, nontoxic, autoclavable, suitable for microscopic monitoring of cell growth and have densities that allow them to be easily kept in suspension, as well as good adhesion properties and high batch-to-batch consistence. 10, 11 To provide such features, several materials have been tested for microcarrier construction, including dextran, plastic, gelatin, glass, collagen, silicone, and cellulose. 10, 11 Consequently, a variety of microcarriers are available (see Table 2 for a selection of commercially available microcarriers and their main characteristics), and the choice should be made according to the cell line and the purpose of the culture. 11 Generally, microcarriers can be classified into micro-and macroporous. The original microporous carriers (i.e., Cytodex 1, 2, and 3) have a small pore size that does not allow cells to colonize the interior and, therefore, are used only for external surface attachment. 11 On the other hand, macroporous carriers (i.e., Cytopore, Cytoline, and Cultisphere) contain open channels, large enough for cells to enter and continue growing, within each bead, providing an increased surface area in comparison to microporous carriers. 11 Consequently, the maximum cell density and productivity achieved is improved. 10 Furthermore, macroporous carriers may provide protection to shear-sensitive cells 11, 85 and are also suitable for the propagation of suspended cells that are entrapped in the porous. 10 To establish an efficient process of microcarrier culture, the full colonization of the available surface should be assured, 11, 86 limiting the number of unoccupied beads at the end of the culture, and achieving a higher cell yield. In processes where detachment of cells from microcarriers is needed, proteolytic enzymes can be used. However, for the production of secreted cell products, as mAbs, this is usually unnecessary.
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Suspensions of microcarriers are usually maintained in spinner flasks for scale-up to large-scale bioreactors.
11 Scaleup of microcarrier cultures is easily accomplished by simply adding new microcarriers into an existing culture, in larger reactors. 10, 11 Cells then begin to colonize the new microcarriers, by bead-to-bead transfer 11, 87 or, more commonly, by cell detachment from confluent microcarrier surfaces, which will occur in a low calcium medium or by a change of pH for some cell lines, or by the use of a cocktail of trypsin and ethilenediamine tetra acetic acid (EDTA) in other cases. 10, 11 STR is the most predominant bioreactor used for microcarrier culture. 9, 88, 89 The density of microcarriers used in this reactor differs with the mode of culture, with the higher densities being used under fed-batch and perfusion modes allowing increased cell concentrations (more than 10 7 cells/ mL) to be achieved. 10, 90 Perfusion is, indeed, the most used operation mode for adherent culture with microcarriers in STR. 9, 88 Retention of the microcarriers can be easily and reliably achieved with spinfilters 91, 92 or other simpler means such as stagnant zones. 93 This is an advantage over suspension cultures in STR, where cell retention is harder to achieve and problems such as filter fouling or incomplete cell retention have been reported. Nevertheless, problems related to agitation have still been encountered. To achieve a good oxygen supply, certain levels of agitation are necessary. However, cells adhered to the microcarriers are sensitive to overagitation and can be detached above critical stirrer rates. 92, 94 Furthermore, entrapment of microcarriers in foam layers generated by direct sparging and the consequent cell damage has also been observed. 95 Fluidized bed bioreactors use porous microcarriers with a specific gravity ([1.6) that allows them to stay suspended in a high-velocity upward-fluid flow of culture medium. 10 In the initial design, this fluidized bed was contained in a column-type bioreactor that was connected to an external recirculation loop, where a gas exchanger, sensors, heating elements, and a circulation pump were located. 10 The major disadvantage of this reactor was the generation of an oxygen gradient along the axis of the column. This limitation can be overcome by the integration of a membrane oxygenation module directly into the fluidized bed 96, 97 or by the integration of an in-line gasification tube module. 98 This last fluidized bed bioreactor ( Figure 6 ) has an improved oxygenation, resulting in its current use in biotech industry for large-scale production of proteins for research and medical applications. 10 However, the available working volumes are still very limited. 10 Concerning disposable bioreactors, particularly wave, little has been reported about its application for microcarrier cultures, 99 particularly for mAb production. Nevertheless, the few studies performed, involving vaccine, 48, 54 adenovirus, 51 and recombinant protein 51 production, have shown successful results on the use of wave for anchorage-dependent culture using microcarriers.
Membrane and fiber bioreactors. Apart from the systems using suspended microcarriers, other alternative bioreactors and matrices for anchorage-dependent cell culture have been tested.
Hollow fiber bioreactors (HFB, Figure 7 ) have been extensively studied for mAb production, 100,101 usually in perfusion mode. 100 These systems try to mimic the in vivo mammalian cell environment. For that, cells immobilized at high density are perfused via thousands of capillaries made from ultrafiltration or microfiltration (semipermeable) membranes. The culture medium contained in a reservoir circulates within the capillaries by the action of a pump, bringing oxygen and nutrients to the cells, and removing the waste products, before returning to the reservoir for recirculation.
102, 103 The oxygenation and pH control is achieved by a gas exchange unit. 102 The HFB systems generally achieve high cell densities with high mAb volumetric productivities, consequence of the use of semipermeable membranes that retain the secreted product in the cell compartment, concentrating the product before harvest. 74, 100 This results in products free from medium-derived contaminants, 102 but with more contamination with dead cells and cell debris, which may put high demands on the purification process. 74 The accumulation of dead cells over time may also result in relatively short operation life. 74 The capillary membrane separation between the cells and the main medium flow provides a low shear environment, which is an advantage over the typical STR system. 100, 102 However, HFBs are difficult to scale up, 74 the large-scale units are expensive, prone to membrane fouling, and have many operation difficulties (mechanical failures and improper feed controls). This may result in low cell viability, process instability, and variable product quality. 101, 104 Fixed or packed bed reactors (FBR) are a widely used alternative bioreactor technology for perfusion culture of immobilized mammalian cells. These reactors are typically composed of a packed bed that supports cells immobilized on or within carriers, a gas exchanger, and a medium reservoir that is used to recirculate the oxygenated nutrient medium through the bed. 105, 106 Therefore, cells are retained in the fixed-bed matrix and the spent medium containing the product that returns to the reservoir can be harvested in batch or continuous mode. 74, 102 FBR can be divided in two major designs (Figure 8) : one where the packed-bed compartment is external to the medium reservoir, and the other where it is contained within. 77, 107 Additionally, the medium flow through the bed may be parallel to its longitudinal axis or radial. 74 Several matrices for cell immobilization have been tested. The initial solid glass beads for growing cells as monolayers 108 were abandoned because of low specific surface-tovolume ratio that resulted in limited cell densities. 74 This led to the introduction of porous glass spheres that provided higher specific surface, increasing cell densities. 106 However, the relatively low internal porosity of these spheres posed some limitations to oxygen diffusion within the carriers. 74 Therefore, the next generation of packing materials has higher internal porosities, and includes glass fibers, 76 ceramic matrix, 109 nonwoven fibers made of polydegradable polymers such as polyglycolic acid (PGA) and polylactic acid (PLA), 110 and non-woven polyester fibrous matrices. 111 Systems with these carriers achieve high cell densities and productivities, 112, 113 showing the great potential of FBR for commercial use. 114 This is mainly due to their characteristics of high porosity and high specific surface area for cell adhesion, good mass-transfer efficiency, relatively low pressure drop and shear rates, ease of operation and scale up, and low costs. 74, 107 The low shear rates observed in these bioreactors favor the application of serum-or protein-free media. 115 Furthermore, the retention of cells in the bioreactor reduces product contamination with cell-derived components, facilitating the downstream processing. 102 Nevertheless, these systems still have some limitations that need to be surpassed, like the severe clogging and channeling over long-term use, 60 the heterogeneity that can be observed (formation of concentration and cell gradients), 102 and still some oxygen transfer limitations. 116 Indeed, these last two limitations are a major drawback to further scale-up of the FBR systems, because of the maximum packed-bed depth of $30 cm they impose. The bed diameter is also limited ($2 m) because of the difficulty of maintaining a uniform distribution of nutrients over the bed. Consequently, the total volume of the bioreactor becomes restricted, with the maximum FBRs volume reported being of 30 L. 105 A derivation of the fixed bed reactor consists of a dialysis bioreactor with radial-flow fixed bed. In this reactor, the two chambers (macroporous carriers-containing and medium-containing) are separated by a cylindrical membrane. The aeration is done in the outer chamber containing the medium that radially flows through the membrane and the cells in the inner chamber, by induction of a centrifugal pump.
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Modes of operation
Bioreactors can operate in different modes of culture, with the following being the commonly mentioned in literature: batch, fed-batch, continuous culture without cell retention (chemostat or cytostat), and continuous culture with cell retention (perfusion). 10, 119 The choice of the best mode of operation depends on the application for which it is intended.
Batch Culture. Batch culture is a simple and reliable process, and therefore, the method of choice for many industrial applications. 49, 120 In this mode of operation, the bioreactor is initially charged/inoculated with cells and medium, 11 and the cells are allowed to reach a determined density and product concentration. 49 At this point, the cell supernatant is collected 49 and the product of interest recovered. The scale-up to larger volumes is simple and basically consists on diluting the content of a bioreactor into 5-20 vol of fresh medium kept prewarmed in a larger reactor. 4 As no additions or withdrawals are performed during batch culture, nutrient concentration will gradually decrease, whereas waste product concentration increases, leading to a gradually deteriorating environment for cell growth. 11 Therefore, the maximum cell density that is possible to reach (usually about 10 6 cells/mL) is dictated by nutrient limitation (glucose, glutamine), waste product inhibition (ammonia, lactate, CO 2 ), 10, 11, 121 or the complete cover of the available growth surface (for anchorage-dependent cells). 11 This contributes for the major limitation of batch culture-the reduced cell yield that is possible to attain, which ultimately results in reduced product concentrations. This limitation can only be surpassed by nutrient supply and/or removal of waste products, 11 as it is attempted in other culture modes.
The time of harvest in batch culture is based on the kinetics of product formation, 122, 123 that is, if the product formation is growth or nongrowth associated. In the first case, the specific productivity increases with increasing growth rate and ceases when the culture is entering stationary phase, whereas for the latter, product formation increases with decreasing growth rate or is only observed during stationary phase. 10 However, the quality of the product should also be an aspect to consider when establishing the time of harvest, because the continuously changing (degradative) composition of the culture medium can affect the quality of the earlier synthesized product. 4 A derivation of batch mode of operation is the repeated batch culture (batch-refeed), where a fraction of the cell suspension is left in the bioreactor when the culture is harvested and fresh medium is added for a new batch cycle. 4, 10 In this operation, it is critical to assure a high viability of the remaining cell suspension and to optimize the time to initiate the new batch. 10 Indeed, basic batch suspension processes have the tendency to become less common, because waste accumulation and nutrient fluctuations can be reduced using nutrient feeding strategies that allow higher cell densities and productivities. 9 Although batch-refeed is the simplest of these strategies, other more efficient modes are also being used, as fed-batch and perfusion.
Fed-Batch Culture. In fed-batch cultures, a controlled nutrient feeding is performed during the course of the culture, 11 in an attempt to increase the culture longevity (particularly important in the production of growth-associated products), 124 ,125 cell yield, 11 and overall productivity. Nutrient feeding strategies include partial medium changes at regular intervals and the addition of specific nutrients at critical stages of the culture. 11, 125 For this, the limiting nutrients should be identified, so that the correct concentration of a specific nutrient is added at precise intervals. 11, 124 It is therefore implied that a better understanding of the effects that culture conditions have on cell viability and antibody production is needed to establish the essential conditions during a fed-batch operation, aiming for the maximization of product formation. 125 However, although fed-batch strategies can alleviate the limiting effects of nutrient depletion, the accumulation of waste products to growth-inhibitory concentrations is not avoided/controlled. 11 Nevertheless, the fed-batch process is often used because of its scalability, ease of operation, and high volumetric productivity. 6, 125 Continuous Culture. A continuous culture consists of an open system with continuous feed of fresh medium and removal of spent medium. 11 This allows cell growth to proceed for longer periods than in a batch or fed-batch culture. This continuous culture can be divided in two main types: chemostat culture and perfusion culture.
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In chemostat culture, cells are removed continuously from the bioreactor with the spent medium. 126 Growth is controlled by the flow rate of fresh medium, expressed as dilution rate (medium flow rate divided by the culture volume), with common values of 0.2-1.0 vol/day (proportion of cell culture volume replaced in 1 day) for mammalian cells. 11 When the cell growth rate is equal to the dilution rate, a steady state of equilibrium is reached, where concentrations of cells, nutrients, and products are constant. 11 These conditions of steady state are always restored if a change occurs, because of the self-regulation of the chemostat system. For example, a temporary decrease in cell concentration will cause a corresponding increase in the growth rate. 11 In perfusion culture, cells are retained in the bioreactor (e.g., by centrifugation, 127 internal and external spin filters, 128, 129 or hollow fiber modules 130, 131 ), whereas the spent medium is continuously replaced with a fresh supply. 63, 132 The continuous supply of nutrients and removal of waste products, as well as cell recycle, results in increased longevity, improved cell density ([10 7 cells/mL), and, consequently, higher volumetric productivity. 130, 132 The residence time of the product in the culture environment is also reduced, which results in improved product quality. 132, 133 For large-scale production, this system appears to be one of the most advantageous.
Process Monitoring
Mammalian cell cultures performed in bioreactors allow the production of mAbs in large-scale quantities. However, this production can be further maximized using different strategies, such as nutrient optimization, feeding, cell engineering, or manipulation of the cellular environment. 134 Among these, the most common practice consists on the optimization of bioreactor culture conditions, because it represents an economical and reliable way to ensure optimal productivity. 134 For this, the culture parameters more relevant for cell growth and productivity need to be identified, and their individual and interrelated effects better understood. Furthermore, methods and technologies for monitoring and control the physicochemical environment in which cells are exposed are essential to achieve productivity improvements in bioreactors. 6 
Parameters
In the optimization of productivity, a balance between cell growth and mAb production 6 needs to be achieved, because the conditions that are optimal for a specific mAb may not be the same for other. Nevertheless, process parameters, such as temperature, pH, osmolarity, DO, CO 2 , and nutrient and metabolites concentration, have been shown to affect cell performance 135 and are, therefore, generally seen as the most relevant for optimization of production in mammalian cultures.
Temperature. Temperature is one of the most critical and more studied variables to monitor for maintenance of healthy cell cultures. 136, 137 Although the ideal growth temperature for most mammalian cells is 37 C (the body temperature), it has been shown that this may not be the best temperature for recombinant protein/mAb production. Indeed, some studies 138, 139 have demonstrated that a lower temperature (around [30] [31] [32] [33] [34] [35] C) may have a positive outcome in terms of mAb specific productivity, while maintaining or improving product quality. 135 However, the increase of the specific productivity does not often results in improved volumetric productivity, because of the negative effects that low temperatures have in the cell growth rate. 140 Therefore, the most advantageous temperature strategy may be culturing cells at 37 C until a high cell density is reached and then shifting to lower temperatures to achieve higher product titers. 141, 142 pH. Along with temperature, pH is considered to be one of the most critical parameters for mammalian cell culture, because of the severe effects its variation can cause to cells. 10, 143 Indeed, even small variations of pH (0.1) can have impact on cell growth, productivity, cell metabolism, and protein glycosylation. 144, 145 Furthermore, optimal pHs for specific growth rate and specific protein production may not be necessarily the same. 145 In bioreactors, pH should ideally be near 7.4 at the beginning of the culture and not fall below 7.0 during culture, 10, 146 although values set between 6.5 and 7.8 are usually acceptable. 6 The highest values of pH are preferred for starting the culture because they favor cell growth. 6 However, they also increase the anaerobic cell metabolism that leads to the accumulation of metabolites (particularly lactate). Therefore, after reaching a desired cell density, pH is usually shifted to a lower value that, although halting cell growth, 45, 146, 147 will improve mAb production. 6, 147 Maintenance of pH stability in culture is affected by different factors, including buffer capacity and type, 10, 146 bioreactor headspace, and glucose concentration. 146 Mammalian cell culture medium is prepared with a buffer system to control pH variations, and it usually consists on the CO 2 bicarbonate system. 146 This system requires the addition of CO 2 to the culture vessel headspace or the addition of bicarbonate base. 146 Nevertheless, other buffer systems can be used to improve buffering and pH stability, such as the zwitterionic buffer 148 (i.e., Hepes), that can be used alone or in combination with bicarbonate, or specialist media such as Leibovitz's L-15. 149 Because the normal buffer system needs a certain level of CO 2 (5%) to maintain a stable pH, it is important that the culture vessel has a large headspace or an open system with continuous flow of air (required in large bioreactors). This will assure that CO 2 generated during cell growth adequately diffuses from the medium, without build-up and consequent decrease in pH.
In addition, glucose concentration in the medium also affects pH. Glucose is metabolized by cells at a greater rate than it is needed and results in the formation of toxic metabolites (pyruvic and lactic acids) that lower pH to nonphysiological levels. 146 To avoid the fast build-up of metabolites and deterioration of the medium, glucose should be added in small concentrations (no more than 2 g/L) to the medium during culture. Other approach is to replace glucose by other carbon sources, such as galactose or fructose, which significantly reduces formation of lactic acid, but also results in slower cell growth. Nevertheless, in large bioreactors, a pH control system is usually essential. 146 Osmolarity. Osmolarity strongly influences mAb production, cell growth, and death rates, as well as the duration of exponential growth. 124 Increases in osmolarity are observed because of additions of base (to control pH) or of glucose or medium concentrates to the culture. 124, 150 The resultant high levels of osmolarity cause decreased growth rates and cell concentrations. However, within a certain range (300-400 mOsm/kg), the osmolarity increase can be beneficial. Indeed, at this range, the negative consequences in cell growth can be compensated with increases on the specific mAb production rate, resulting in a higher final antibody concentration. 151 For this reason, hyperosmolarity is sometimes described as one alternative to improve mAb production, with the advantage of being more economical than others. 152, 153 Dissolved Oxygen. Mammalian cells require oxygen for the production of energy from organic carbon sources. 10, 143 Therefore, oxygen available for cell use (DO) is an important parameter for mammalian cell culture. The amount of DO in the medium is dependent on a diversity of factors, such as cell growth rate, carbon source, 10 and specific rate of consumption by the cells, 154 that leads to a state of dynamic equilibrium of DO. 10 Although DO may not negatively affect cell growth and production levels within a large range (pO 2 between 20 and 100% of air saturation), 6, 146 it can have negative consequences on product quality (glycosylation). 6, 155 Furthermore, scale-up represents a problem for guaranteeing correct levels of DO in the culture, because the methods currently available for that purpose cannot assure high cell oxygenation without causing some cell damage (see next section). 146 Carbon Dioxide. CO 2 is known to have an essential role in mammalian cell culture to maintain the culture pH at the normal optimum range and to regulate many cellular activities. 156 Therefore, the concentration of CO 2 should be maintained at physiological levels (partial pressure of $50-70 mmHg at 37 C 157 ). 158 However, during scale-up in largescale bioreactors, the CO 2 partial pressure tends to build up to levels higher than physiological, causing significant problems in mammalian cell culture. [159] [160] [161] In fact, it has been shown that high dissolved CO 2 concentrations can have detrimental effects on cell growth, nutrient utilization, product formation (productivity), and product quality. 158, 162, 163 These detrimental effects must be carefully considered during optimization of mammalian cell culture process, to achieve higher productivities and better product quality. 158, 164 Nutrient and Metabolites Concentration. Nutrients present in the medium are the support for cell growth, and their exhaustion can jeopardize cell growth rates. 146, 164 Among the nutrients needed for cell culture, glutamine and glucose are considered as the most critical/limiting ones, which is evident from the reduction of cell growth rate that occurs even before these nutrients are totally consumed. 146 Furthermore, as mentioned earlier, consumption of glucose by cells, especially when present at high concentrations in the medium, is done at a higher rate than necessary. This leads to the rapid accumulation of toxic metabolites (lactate, ammonia) that can inhibit cell growth and/or protein productivity, 165 as well as affect product's glycosylation. 166 To avoid this, some attempts have been made, which include reduction of ammonia formation by controlling glutamine concentration, 90 modification of the energy metabolism by controlling glucose concentration (e.g., by feeding less glucose to the culture but more periodically, in concentrations according to cell needs), 165, 167, 168 or replacement of glucose by a slower utilized substrate such as galactose. 169 Apart from the control of the main nutrients, other compounds may be added to the medium to reach an optimal culture performance. These include growth factors and hormones such as insulin, transferrin, ethanolamine, and selenium. 170 Glycosylation. Mammalian cell lines are the host of choice for the production of therapeutic mAbs especially because of their ability to perform correct post-translational modifications, particularly glycosylation, which has a major effect on the biological properties of the product (pharmacokinetics, bioactivity, secretion, in vivo clearance, solubility, receptor recognition, and antigenicity). 171, 172 Hence, it is essential to ensure that a consistent glycosylation profile is maintained between batches in the process of production. 6, 173 However, culture conditions, such as temperature, pH, 174 DO, CO 2 , osmolarity, 175 time of culture, 176 as well as nutrient and metabolite concentrations, 174, 175, 177 have been shown to affect glycosylation. 6, 178, 179 Therefore, it is of extreme importance to have a further understanding of the parameters that control protein glycosylation in bioreactors, and to monitor product quality during each step of the optimization, to be able to ensure the quality and consistency needed for biopharmaceutical production.
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On-line/off-line control During bioreactor culture, it is important to assess the culture health. For this, several key parameters are routinely measured, such as pH, DO, dissolved CO 2 , temperature, nutrients and metabolites concentration, cell density and viability, as well as product concentration and quality. Monitoring these parameters allows the follow-up of culture growth and metabolism, and in case of decline of cell health it helps identifying the cause (starvation, bacterial contamination, or bioreactor equipment failure). To be able to efficiently and timely intervene in the culture to maintain cell health, this monitoring should ideally be performed on-line, in real-time. However, this is currently only possible for some parameters (temperature, pH, DO, and dissolved CO 2 ), whereas others (cell density/viability, nutrient and metabolites concentration, mAb concentration, and quality) are still analyzed using offline techniques. 6 Nevertheless, efforts are being made to develop methodologies that will allow the on-line monitoring of such parameters.
Temperature. Temperature is a major player in culture optimization, and as such, instrumentation and strategies developed for its control should be highly accurate ( 0.5 C is considered adequate 180 ). 10 The most commonly used instrumentation is the resistance temperature devices (RTDs) (usually made of platinum), which combine characteristics of high accuracy, high reproducibility, and fast response time with moderately high costs. With lower costs than RTDs are the thermocouples that, however, give less accurate and stable temperature measurements. 10 Control of temperature in mammalian cell cultures has been using systems regulating the temperature or flow rate of water in an external water jacket or in internal heating or cooling coils. 10 Moreover, although in laboratory-scale bioreactors the control can be on-off, in larger bioreactors a more precise control is needed. For this, proportional-integral (PI) or proportional-integral-derivative (PID) control schemes can be applied. 181 pH. pH monitoring is currently performed on-line, using an autoclavable pH probe (usually electrochemical probes 143 ) that feeds a signal that is transformed into an analogue or digital display of the culture pH. 146 This allows direct and continuous measurements to be taken, providing information on both growth and cellular metabolism, because they are strongly dependent on medium pH. 182, 183 To control pH, maximum and minimum acceptable pH values need to be set, so that pH is maintained within a defined range. 146 If the culture pH drifts away from the range established, the system activates pumps that add acid or base to the culture to set it back into the desired values. 10, 146 Though, usually, only base additions are needed (often KOH, NaOH, NaHCO 2 , or Na 2 CO 3 10 ), since cell metabolism results in pH decrease. 10, 146 Furthermore, the pH monitoring system also involves control of the gas supply, more particularly, CO 2 additions to the medium. If pH is above the set point, CO 2 will be delivered to the culture, but if it is below this value, only air, oxygen, or a mixture of both will be added. 146 Moreover, pH control is helped by the buffering capacity of most mammalian cell culture media. 10 Apart from glass electrodes, other methods have been developed for pH quantification, such as optical and fiber-optical pH sensors. 143, 184, 185 These sensors can be based on conductive polymers, imaging fibers, microparticles and nanospheres, as well as micrometer, submicrometer, and distributed fiber-optic sensors. Other pH sensors include acidity and alkalinity sensors, pH sensors with broad dynamic range and linear response, and CO 2 and NH 3 sensors based on pH indicators.
Dissolved Oxygen. The direct and continuous monitoring of DO provides important information about growth and cellular metabolism rates. 183, 186 For this, quantification of DO is usually performed amperometrically, using a Clark-type electrode that consists of an electrode covered by a membrane that is selectively permeable to oxygen. 187 Additionally, a spectrophotometric method based on a colorimetric technique 188 can be used, which has a sensitivity lower than the amperometric method but still higher than needed for cell culture. 10 Another alternative is the use of oxygen sensors based on fluorescent quenching of suitable dyes, 189, 190 which show good stability and reversibility. 10 Actually, optical sensors have been developed for the measurement of oxygen levels in culture. 143, 185, 191 To control the oxygen levels in culture, different methods (or a combination) can be used. In smaller cultures, the maintenance of a large headspace volume is extremely important and usually sufficient to assure no oxygen limitation to cells. 146 In larger reactors, however, other methods need to be used to guarantee adequate oxygen supply. These include sparging, membrane diffusion, medium perfusion, increasing of the partial pressure of oxygen, and increasing of the atmospheric pressure. 192 Sparging consists of bubbling gas through the cell culture but, although very efficient, it can cause damage to the cell membrane because of the high surface energy of the bubbles. 146 These negative effects can be minimized by using larger air bubbles, a very low gassing rate or by adding Pluronic F-68 (a shear protectant) to the medium. For its turn, the membrane diffusion method uses tubing of very gas-permeable silicone arranged in the bioreactor to achieve sufficient oxygen diffusion. However, because of the large quantities of tubing required, the method is expensive and inconvenient to use and also difficult to scale-up. 146 A more advantageous method is the medium perfusion, in which the medium is continuously (or on demand) taken from the culture and passed through an oxygenation chamber before returning to the culture. As the medium is separated from the cells, it can be conveniently sparged to ensure oxygen saturation without damaging cells. 146 Furthermore, when the bioreactor culture is already advanced, DO concentration can be increased by raising the headspace oxygen pressure (pO 2 ) and/or the pressure of the culture (to increase the oxygen solubility and diffusion rate). 146 Dissolved CO 2 . Although in mammalian cell culture DO is the parameter most often used for on-line monitoring and feed control, 193 dissolved CO 2 is another component of interest that can be used as an indicative of the cellular metabolism.
10 CO 2 measurements can be performed with offline sensors, but these are limited by the low frequency of data collection (not allowing continuous control) and the need for sampling. 157 Therefore, attempts to develop in situ CO 2 sensors have been made. Commonly, CO 2 is quantified in the gas phase using relatively inexpensive infra-red analyzers, which require stable temperature and consistent levels of moisture in the vapor environment. 10 More recent techniques, for CO 2 quantification in the medium, include sensors that use a gas-permeable membrane to separate a bicarbonate buffer from the analyte solution and a glass pH electrode, 194 and optic fiber probes that use a pH sensitive dye and an optical fiber (e.g., the commercialized YSI 8500 sensor). 157, 195 Other alternative methodologies to monitor CO 2 include gas chromatography and mass spectrometry, which has a rapid response time and high sensitivity, being one of the most promising techniques. 10 Cell Density and Viability. The success of a mammalian cell culture is typically evaluated by cell density and viability, because the goal of a culture scale-up process is to maximize the total number of viable cells in the minimal amount of time. 196 The common practice for the assessment of cell density and viability is to take daily samples from the bioreactor and to perform off-line measurements. The off-line methodologies used can be direct or indirect 197 and can assess both density and viability or just one of these parameters. For direct measurements, a hematocytometer is commonly used, allowing microscopic cell counting. In conjugation with a dye exclusion test, it becomes possible to simultaneously assess cell viability, based on the concept that viable cells do not take up certain dyes (e.g., trypan blue or erythrocin) in opposition to dead cells. 146 Automated cell counters are also available for direct assessment of cell growth and viability (e.g., Microcyte, 198 Nucleocounter, and Guava PCA 200 ), 6 as well as colorimetric methods 3-(4,5-Dimethylthiazol-2-41)-2,5-diphenyltetrazolium bromide (MTT assay). 5 On the other hand, indirect methodologies for both density and viability analysis are usually based on metabolic activity (glucose or oxygen uptake; lactic, pyruvic acid, or CO 2 production) or the expression of a product. 146, 201 Cell density can also be indirectly assessed by total cell mass measurement through total protein or dry weight determination. 146 The indirect methods are not as accurate as the direct techniques, because the correlations between the specific metabolic rates measured and cell density/viability vary with the growth phase of cells. 146, 202 Nevertheless, these methods can be very useful in situations where cells cannot be sampled, such as most anchorage-dependent cultures, or visually examined. 146 Off-line measurements of these parameters are the common procedure currently used. However, ideally, the assessment of cell density and viability should be performed on-line, inside the bioreactor, without the need for sampling. This would allow a frequent or even continuous (real-time) monitoring, providing early indications of catastrophic events as contamination or cessation of growth, 183 and helping to ensure that medium additions to the culture occur at appropriate times. 201 Strategies for such measurements have been developed and include turbidity, 203 oxygen uptake rate, dielectric spectroscopy, 204 near-infrared (NIR) spectroscopy, 205 capacitance detection 204 flow injection flow cytometry, 206, 207 optical microscopic imaging, 208 CEDEX cell counter, 201 and optical sensors. 143 However, most of these methods have low sensitivity or are affected by medium debris and are usually unable to measure cell concentrations below 5 Â 10 5 cells/mL.
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Nutrient and Metabolites Concentration. Culture health is strongly dependent on nutrient and metabolite concentrations in the medium. Therefore, efforts have been made to develop methodologies for monitoring these parameters. Because of its importance, glucose and glutamine, as well as their metabolic products (ammonia, lactate, and glutamate) are the main concern in such developments. However, recent evidence suggests that monitoring of a greater number of components in bioreactors may be needed to sustain a health culture. 209 Indeed, ideally, all or nearly all of the high-level components in a cultivation should be tracked.
Although, currently, nutrient and metabolite monitoring still focus mostly on the main components, with the common practice consisting of taking period samples from the bioreactor and performing off-line analysis, this analysis usually involves high-performance liquid chromatography (HPLC) 6, 167, 168 or the recent and faster ultra-performance liquid chromatography (UPLC) [210] [211] [212] (amino acids), commercially available analyzers such as the YSI analyzer (glucose, lactate, ammonia) 6, 167, 168, 213 and enzyme-based or spectrophotometric assay kits (ammonia, glutamine). 10, 167, 168 Developments on on-line control include methods of chromatography, enzymatic conversions, flow injection, and optical sensing. 214 On-line chromatography analysis was the first to be applied, but it requires substantial time for measurements and the periodic removal of samples, implying a risk of bioreactor contamination and loss of some amount of product. 10 In this sense, enzymatic sensors can be very useful, as they provide rapid measurements from within the bioreactor. 10 However, these sensors have problems related to the need for frequent recalibrations and for the separation of the enzyme from the bioreactor environment, and therefore, measurements using these enzymatic biosensors are usually performed off-line. 10 Another technology developed for on-line monitoring is the flow injection analysis (FIA), which uses different detection methods, namely amperometry, potentiometry, fluorescence, chemiluminescence, UV-vis absorbance, or turbidometry. 215 FIA has a low risk of contamination, is easy to recalibrate, requires small samples, and provides a rapid analysis. 10 It has been used for measurements of glucose, 216, 217 glutamine, 216 glutamate, 188 ammonia, 218 and lactate 217 concentrations. Though, each FIA sensor can monitor only one analyte and often does not possess enough sensitivity and selectivity. 219 The need for sampling from the reactor before analysis can be eliminated by the use of spectroscopic methods. They allow real-time monitoring of multiple analytes without sample preparation and in a noninvasive and nondestructive way. 10 These optical sensors can use visible, UV, or NIR light and have been applied in the measurement of glucose, [220] [221] [222] glutamine, 220-222 ammonia, 220,222 lactate, 220, 222 glutamate, 222 sucrose, 223 fructose, 223 maltose, 224 and asparagines 221 concentrations.
MAb Concentration. Conventionally, mAb production is quantified using methods as the standard enzyme-linked immunosorbent assay, 225 Western blot, protein A HPLC, and bioassays. 226 However, these methods are time-consuming, variable, and require substantial amounts of cell culture samples. 226, 227 Therefore, methods allowing real-time monitoring of mAb concentration would be extremely useful to accelerate cell line screening and optimization of culture parameters. 227 For this purpose, the use of fluorescence intensity has been tested, and it has been observed that it allows the screening of a higher number of clones than the conventional assays. This significantly reduces the effort and time spent for screening and improves the chances of identifying high producers. 228 More recently, a mass spectrometer connected to a bioreactor has been used to quantify multiple proteins in the culture media, 229 as well as a surface plasmon resonance-based biosensor that allows on-line follow-up of the relative concentration of the protein of interest. 226 This last method has showed potential to on-line analysis of protein bioactivity. 226 Furthermore, innovative approaches have been emerging from the nanotechnology field, which will enhance sensitivity to the level of single molecule detection. These include metallic nanostructures (with unique optical properties) for the detection of biomolecule interactions, 230 ,231 combination of metallic nanoparticles and nanofilms with fluorescent probes, 232, 233 and combination of metal-enhanced fluorescence and phase modulation fluorometry. 227 These advances will contribute for the development of compact benchtop or handheld instruments for mAb quantification, similar to those routinely used for glucose monitoring. 227 Post-Translational Modifications. Post-translational processing is required to obtain a fully biologically active mAb. Among the post-translational modifications, glycosylation is one of the most important, 175 playing critical roles in protein folding, activity, immunogenicity, and protease sensitivity in vivo. 234 Several techniques are available to analyze glycosylation of the product obtained from mammalian cell culture. 235 This analysis is important to ensure quality and stability of the product, as well as batch consistency, and can be based on different physical or chemical characteristics of the glycoprotein. 10 Broadly, four methods can be used: (i) separating the glycoprotein by glycoforms, (ii) determining the glycoprotein monosaccharide content, (iii) cleaving oligosaccharides from the glycoprotein, and (iv) degrading the glycoprotein via peptidases. 236 To meet FDA requirements of glycoprotein characterization, at least two of these analytical methods need to be performed. 10 For each of these methods, different techniques can be used, with the more common being electrophoresis, liquid chromatography (LC), mass spectrometry (MS), nuclear magnetic resonance (NMR), and exoglycosidase digestion. 10, 237, 238 The choice of the appropriate technique is based on several factors, namely the amount of sample required, cost per sample, desired resolution, and availability of equipment and technical expertise. 10 For the first method, whole or intact proteins are directly analyzed based on size, charge, affinity, and oligosaccharide content, using sodium dodecyl sulfate polyaceylamide gel electrophoresis (SDS-PAGE), isoelectric focusing polyacrylamide gel electrophoresis (IEF-PAGE), ion exchange chromatography (IEC), 2D-PAGE, Western blots, capillary electrophoresis (CE), matrix-assisted laser desorption ionization mass spectrometry (MALDI-MS), and exoglycosidase digestion. 10 This method is relatively easy, fast, and inexpensive, but only allows a low level of resolution for the glycosylation analysis. 10, 238 For these reasons, this analysis is commonly used only to assess batch consistency of protein glycosylation. 239 The second method involves the analysis of monosaccharides that are obtained directly from an intact glycoprotein or glycopeptides pool. 10 Such analysis can be performed by different analytical techniques as fluorophore-assisted carbohydrate electrophoresis (FACE), HPLC, 240 MALDI-MS, and NMR, which give more detailed information about identity, composition, anomericity, and linkages of the monosaccharides. 10 In the third method, oligosaccharides are obtained from glycoproteins and glycopeptides (chemically or enzymatically) 239, 241 and analyzed, with varied degrees of accuracy, by FACE, CE, HPLC, fast-atom bombardment mass spectrometry (FAB-MS), electrospray mass spectrometry (ES-MS), MALDI-MS, liquid chromatography mass spectrometry (LC-MS), 238 NMR, or exoglycosidase digestion. 10 Information about mass, composition, linkages, and sequence can be obtained, 10 with LC-based methods being the most accurate.
The last method also allows the analysis of glycopeptides that are obtained from the proteolytic digestion of the glycoprotein. For this, the techniques used are IEF-PAGE, CE, HPLC, FAB-MS, ES-MS, MALDI-MS, LC-MS, and exoglycosidase digestion. 10 Besides glycosylation, other post-translational modifications are important to maintain the structure and function of a mAb molecule, such as deamidation, isomerization, oxidation, proteolysis, and aggregation. 174, 242 The methods typically used to analyze these modifications include cationexchange chromatography (CEX), 243 isoelectric focusing (IEF), 243 hydrophobic interaction chromatography (HIC), 244 CE, 245 MS, 243 and reverse-phase HPLC-MS (RPLC-MS). 246 
Scale-Up
The aim of process scale-up is to obtain larger quantities of the product, maintaining high levels of productivity and product quality. 247 For this, both physical (configuration of the bioreactor) and chemical requirements of cells have to be satisfied, so that cells are kept in the proper physiological environment. However, satisfying these requirements during scale-up to industrial level is a challenging process, since the many different factors involved interconnect and sometimes compete between themselves. 60, 247, 248 Parameters such as temperature, DO, and pH are all volume independent and, therefore, are set for larger bioreactors at the same levels as for smaller bioreactors. 248 On the other hand, the total air flow rate as well as CO 2 and oxygen flow rates have to be changed according to the culture working volume, to maintain a normalized volumetric flow rate. This is simply obtained by dividing the total air flow rate by the volume. 248 However, because of problems related with low mixing rates, accumulation of CO 2 becomes a recurrent issue in scale-up, 160, 161 because it has been shown to cause inhibitory effects on cell growth and antibody production 152, 160, 162 and quality. 159 Indeed, the agitation rate is one of the most critical 249 and difficult parameters to scale-up, because it needs to provide sufficient mixing (for good mass transfer and homogeneity) in the larger bioreactors and, simultaneously, not cause too much stress and damage to the cells. 45, 248, 249 A good balance is hard to attain, and usually pH and nutrient gradients are present in large-scale bioreactors because of poor mixing, 250, 251 which result in reduced cell growth and antibody production. 252 Moreover, changes on the agitation speed may impact other parameters that should be maintained during scale-up, such as the critical 253 oxygen transfer coefficient. 248 Therefore, this will imply the adjustment of other conditions that would otherwise be simple to scale-up.
During scale-up, nutrient limitation is another factor to consider, with feed additions needing some adjustments. Although the schedule of feed additions is maintained across scales, the feed volume and rate need to be changed according to the volume. 248 As the feed stock is usually more concentrated for large-scale production, because of ease of preparation, handling, and storage, this concentration factor should also be considered in the scale-up. 248 Furthermore, in large-scale bioreactors the delivery of multipulse feeds is usually combined as a single addition to save time and ease of operation. This may imply a change on the method of delivery of the feed media. 248 Finally, inoculation and sampling is modified in largescale bioreactors. Cell concentration should be kept constant across scales. For this, inoculation at different scales should use an inoculum of the same in vitro age (to maintain a similar starting biological status of cells) and a similar inoculum percentage (v/v) (to yield a comparable volume increase from inoculation). For its turn, the frequency and size of culture sampling must be defined for each scale. Particularly, the volume losses during sampling should be carefully accounted for in developing the scale-up strategy. 248 
Conclusions
With the recent advances in medicine, mAbs have assumed an increased importance in the biopharmaceutical industry, especially because of their characteristics of specificity and selectivity. 9 Indeed, currently, they are the fastest growing biopharmaceutical product, with applications in diagnosis and therapy. 164 Furthermore, the need for high doses of mAbs has led to the rapid development of processes for their large-scale production in mammalian cells, to cope up with the market demands. 8 Consequently, several production systems have emerged, with specific characteristics, that can be used for different applications, such as adherent or suspension cell culture. However, the systems developed still have major limitations, especially in oxygenation, monitoring, and control of culture conditions, making it currently difficult to reach the full potential of mammalian cells for mAb production.
To surpass these limitations, a greater knowledge on cells and on the diversity of factors that affect their growth and productivity, as well as the factors interactions has to be obtained. Furthermore, more comparative studies about the production technologies already available are still needed. The combination of an increased know-how about technologies and cell behavior will allow the implementation of more sustained and structured processes of optimization, replacing the current practices based on empirical knowledge and trial-and-error experimentation. This may result in the development of new platforms of cell-culture processes for mAb production that will reduce costs, simplify the procedures, and ultimately speed-up the delivery of the new products to the market.
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